Register entry

Nipro Pharma Corporation

Data as of · How to read this entry

Registered sites
2
Active NDC listings
2
Live patents
0
Countries
1
Base
Japan
Authorisation

Registered operations

Analytical testing2Finished drug manufacture2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Nipro Pharma Corporation428, Okanouchi, Kagamiishi-machi, Iwasegun, Fukushima 969-0401, Japan (JPN)Analytical testing, Finished drug manufacture3010317053693428221
NIPRO PHARMA CORPORATIONAZAMAEDANO5-7, NIIDA, ODATE, 018-5751, Japan (JPN)Analytical testing, Finished drug manufacture3017952330717831064
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.

Dosage formNDCs
injection, powder, lyophilized, for solution1
tablet1
RouteNDCs
Labeller name on the listingNDCs
nipro pharma corporation2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
-Ceftobiprole Medocaril Sodium for Injectioninjection, powder, lyophilized, for solution72122-004DRUG FOR FURTHER PROCESSING
-gefitinib tabletstablet72122-001DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in Japan

Enquiry

Common questions

Is Nipro Pharma Corporation FDA approved?
Nipro Pharma Corporation holds 2 FDA-registered establishments in Japan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Nipro Pharma Corporation's drugs manufactured?
The FDA register lists Iwasegun; ODATE. Registered operations: analytical testing, finished drug manufacture.
What drugs does Nipro Pharma Corporation make?
2 products are listed under Nipro Pharma Corporation in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.